Indeed we observed the same mechanism in three patient-derived colon cancer cell lines carrying BRAFV600E (Pt-1), KRASG13 (Pt-3) and wt BRAF and KRAS (Pt-2). Here, KRAS is linked to malignant colon neoplasm.